title: Demonstration of the presence of IL-16, IL-17 and IL-18 at the murine fetomaternal interface during murine pregnancy.
abstract: OBJECTIVE
  To determine if interleukin-16 (IL-16), IL-17, and IL-18 are present at the murine fetomaternal interface during pregnancy as a first step towards investigating their roles in fetomaternal relationship.
  
  
  METHODS
  Expression of IL-16, IL-17, and IL-18, was assessed by immunohistochemistry (IHC) in the BALB/c x BALB/k (H2d x H2k), and the CBA/J x BALB/c non-abortion prone, and CBA/J x DBA/2 abortion prone matings. Enzyme-linked immunosorbent assay (ELISA) were performed for the two latter cytokines to compare local production in the abortion prone CBA/J x DBA/2 versus the non-abortion prone CBA/J x BALB/c matings.
  
  
  RESULTS
  Expression of IL-17 was borderline. The anti-IL-16 staining specifically localized in the uterine stroma and glandular epithelium and was rather low in the placenta. IL-18 staining started in the peri-implantation uterus in the basal proliferative stroma, and was also traced, although weaker, in the glandular epithelium. In the immediate post-implantation period, a weak stromal staining persisted but there was a strong labeling of the ectoplacental cone. Interestingly, when the ectoplacental cone differentiates into placenta having a major histocompatibility complex (MHC) class I + spongiotrophoblast and a (MHC class I-) labyrinth, a very strong transient labeling of uterine natural killer (u-NK) cells was found. Later in gestation, IL-18 was also produced by giant cell and spongiotrophoblast. Finally, we compared by ELISA the production of IL-17/-18 in CBA/J x DBA/2 and CBA/J x BALB/c matings. We detected significantly more IL-18 in the non-abortion prone combination decidua or placenta.
  
  
  CONCLUSIONS
  The three cytokines IL-16, IL-17, and IL-18 were detected at the fetomaternal interface with a tissue specific, stage-dependent distribution. The predominance of IL-18 secretion in the non-resorption prone matings lead us to question the general validity of the classical T-helper (Th)1/2 paradigm.
authors.affiliation: Department of Biology, Faculty of Medicine, University of Rijeka, Rijeka, Croatia.
authors.forename: S
authors.initials: S
authors.lastname: Ostojic
authors.forename: S
authors.initials: S
authors.lastname: Dubanchet
authors.forename: G
authors.initials: G
authors.lastname: Chaouat
authors.forename: M
authors.initials: M
authors.lastname: Abdelkarim
authors.forename: C
authors.initials: C
authors.lastname: Truyens
authors.forename: F
authors.initials: F
authors.lastname: Capron
mesh_terms: D000818:Animals; D003656:Decidua / Q000378:metabolism; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D007150:Immunohistochemistry; D019410:Interleukin-16 / Q000032:analysis / Q000378:metabolism*; D020381:Interleukin-17 / Q000032:analysis / Q000378:metabolism*; D020382:Interleukin-18 / Q000032:analysis / Q000378:metabolism*; D051379:Mice; D010920:Placenta / Q000378:metabolism*; D011247:Pregnancy; D013997:Time Factors
chemical_list: D019410:Interleukin-16; D020381:Interleukin-17; D020382:Interleukin-18